07/16/2025
6:02 PM | Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
06/20/2025
3:21 PM | Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:22 PM | Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:23 PM | Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:23 PM | Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:24 PM | Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:00 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
7:27 AM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
05/16/2025
3:44 PM | Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
3:45 PM | Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
3:46 PM | Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ADVM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adverum Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. |
05/06/2025
8:15 AM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
04/28/2025
2:24 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
2:31 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4/A | |
04/24/2025
8:35 AM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2025
6:30 AM | Adverum Biotechnologies (Filer)
| Form PRE 14A | |
04/15/2025
6:30 AM | Adverum Biotechnologies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2025
6:43 AM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
5:07 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
6:06 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
7:02 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:04 PM | Adverum Biotechnologies (Issuer)
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:59 PM | Adverum Biotechnologies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
5:10 PM | Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
2:25 PM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
12/19/2024
3:14 PM | Adverum Biotechnologies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/17/2024
4:11 PM | Adverum Biotechnologies (Subject)
Rush Ryan Bradford (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
5:40 PM | Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G/A | |
11/14/2024
5:57 PM | Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
4:49 PM | Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
11/04/2024
3:42 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:44 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
11:41 AM | Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
10/30/2024
8:34 PM | Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
| Form SC 13G | |
10/23/2024
12:34 PM | Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
| Form SC 13G | |
10/22/2024
5:06 PM | Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
3:08 PM | Adverum Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:10 PM | Adverum Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
3:24 PM | Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
07/18/2024
8:16 PM | Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Free ADVM Stock Alerts